|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-10-22 EDT
|
5-day change | 1st Jan Change | ||
| 20.40 SEK | -1.21% |
|
+2.93% | -4.00% |
| 10-02 | Genovis board member increases holding | FW |
| 10-01 | Genovis Chairman Torben Jörgensen Buys Shares for SEK0.85m | FW |
Company Valuation: Genovis AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 4,779 | 3,008 | 3,404 | 1,617 | 1,404 | 1,376 | - | - |
| Change | - | -37.05% | 13.17% | -52.5% | -13.18% | -1.97% | - | - |
| Enterprise Value (EV) 1 | 4,698 | 2,935 | 3,281 | 1,448 | 1,241 | 1,269 | 1,236 | 1,200 |
| Change | - | -37.52% | 11.78% | -55.88% | -14.29% | 2.3% | -2.6% | -2.91% |
| P/E | 178x | 242x | 55.3x | 49.4x | 59x | 70.3x | 40.8x | 28.9x |
| PBR | 41.9x | 23.9x | 17.9x | 7.1x | 5.15x | 4.86x | 4.34x | 3.77x |
| PEG | - | -4.5x | 0x | -1.1x | -2.1x | -3.6x | 0.6x | 0.7x |
| Capitalization / Revenue | 51.4x | 29.4x | 21.5x | 12.4x | 10.9x | 9.32x | 7.36x | 5.85x |
| EV / Revenue | 50.5x | 28.7x | 20.7x | 11.1x | 9.62x | 8.6x | 6.61x | 5.1x |
| EV / EBITDA | 155x | 123x | 51.3x | 25.8x | 37x | 30.8x | 19.6x | 14.1x |
| EV / EBIT | 191x | 170x | 58.8x | 45.1x | 58.3x | 59x | 29x | 20x |
| EV / FCF | 115x | -618x | 59.7x | 28.1x | -57.8x | 79.8x | 36.9x | 33.9x |
| FCF Yield | 0.87% | -0.16% | 1.67% | 3.56% | -1.73% | 1.25% | 2.71% | 2.95% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.41 | 0.19 | 0.94 | 0.5 | 0.36 | 0.29 | 0.5 | 0.705 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 93.02 | 102.4 | 158.2 | 130.4 | 128.9 | 147.6 | 187.1 | 235.4 |
| EBITDA 1 | 30.31 | 23.91 | 63.95 | 56.18 | 33.56 | 41.15 | 63.2 | 85.15 |
| EBIT 1 | 24.54 | 17.28 | 55.8 | 32.07 | 21.28 | 21.5 | 42.6 | 60.15 |
| Net income 1 | 24.78 | 11.19 | 61.5 | 32.92 | 23.5 | 12 | 33.7 | 47.8 |
| Net Debt 1 | -81.32 | -72.83 | -123.3 | -169.4 | -163.2 | -107 | -140 | -176 |
| Reference price 2 | 73.00 | 45.95 | 52.00 | 24.70 | 21.25 | 20.40 | 20.40 | 20.40 |
| Nbr of stocks (in thousands) | 65,466 | 65,466 | 65,466 | 65,466 | 66,063 | 67,458 | - | - |
| Announcement Date | 2/8/22 | 2/15/23 | 2/15/24 | 2/14/25 | 2/12/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 71.21x | 8.71x | 31.25x | - | 141M | |
| 29.59x | 3.89x | 15.41x | 2.56% | 174B | |
| 23.21x | 4.54x | 15.84x | 1.21% | 114B | |
| 19.89x | 3.46x | 12.4x | 3.05% | 114B | |
| 30.39x | 2.95x | 11.92x | 2.36% | 89.64B | |
| 18.67x | 0.21x | 13.47x | 0.7% | 64.96B | |
| 31.91x | 8x | 20.56x | 1.24% | 56.09B | |
| 38.54x | 3.57x | 12.15x | 2.04% | 52.94B | |
| 37.48x | 9.31x | 26.04x | -.--% | 43.6B | |
| 39.32x | 3.19x | 11.88x | 0.55% | 32.77B | |
| Average | 34.02x | 4.78x | 17.09x | 1.52% | 74.21B | |
| Weighted average by Cap. | 27.97x | 4.07x | 15.05x | 1.86% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- GENO Stock
- Valuation Genovis AB
Select your edition
All financial news and data tailored to specific country editions
